Suppr超能文献

咽上肿瘤的预后因素:对1948年至1977年间在弗赖堡(布赖斯高)接受治疗的151例患者的回顾性分析(作者译)

[Prognostic factors in epipharyngeal tumors: a retrospective analysis of 151 patients treated at Freiburg (Breisgau) between 1948 and 1977 (author's transl)].

作者信息

Slanina J, Wannenmacher M, Mittermayer C, Allgeier G

出版信息

Strahlentherapie. 1979 Aug;155(8):529-35.

PMID:382444
Abstract

From 1948 through 1977, 151 patients with an epipharyngeal tumor underwent radiation therapy at our department. A retrospective analysis was made reviewing treatment results and prognostic features. The 5-year survival rate of the total group amounted to 39%, the 10-year survival to 27%. Tumor stage and histology were confirmed as the preponderant factors in prognostication. Stage T1--2 cases had a 5-year survival rate of 57%, which decreased to 46% if unilateral lymph node metastases had occurred, and down to 17% in case of bilateral metastasition to the lymph nodes. Of stage T3--4 patients, 45% survived during 5 years. Lymphoepithelial carcinoma, with a 5-year survival rate of 54%, had a better prognosis than squamous cell carcinoma (47%), transitional cell carcinoma (30%) and reticulum cell sarcoma (30%). A review of the results other authors have obtained since 1956 with combinations of surgical and irradiation methods gives evidence that the efficiency of techniques confined to local or regional treatment has reached its limits. At present, further improvement may be achieved mainly by means of systematically applied adjuvant chemotherapy complementary to the general thérapeutic concept.

摘要

1948年至1977年期间,151例下咽肿瘤患者在我科接受了放射治疗。对治疗结果和预后特征进行了回顾性分析。全组5年生存率为39%,10年生存率为27%。肿瘤分期和组织学被确认为预后的主要因素。T1 - 2期病例的5年生存率为57%,如果发生单侧淋巴结转移,生存率降至46%,如果双侧淋巴结转移,则降至17%。T3 - 4期患者中,45%存活5年。淋巴上皮癌的5年生存率为54%,预后优于鳞状细胞癌(47%)、移行细胞癌(30%)和网状细胞肉瘤(30%)。回顾自1956年以来其他作者采用手术和放疗相结合方法所取得的结果表明,局限于局部或区域治疗的技术效率已达到极限。目前,主要通过系统应用辅助化疗来补充总体治疗理念,可能会取得进一步的改善。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验